REQUEST FOR PROPOSALS #2025-06 ESRD Population Risk-Based Management

CareOregon has issued a Request for Proposals for a three-year contract starting February 2026, with two optional one-year renewals, seeking a risk-bearing entity to provide population health management services specifically targeting members with early-stage kidney disease through End Stage Renal Disease (ESRD). The contractor will be responsible for designing and implementing a kidney care program that proactively manages these members, ensuring comprehensive care coordination, risk adjustment, outcome measurement, and delivery of all entitled benefits. This includes leveraging data-driven interventions, clinical staffing models, and technology tools aligned with CareOregon’s clinical goals and regulatory compliance. The program places a strong emphasis on continuity of care, promotion of various dialysis modalities, and maintaining high standards of performance as measured through clinical outcomes and historical performance metrics. The solicitation prioritizes a thorough evaluation based primarily on the technical approach (35 points), including clinical and staffing models and intervention strategies, followed by the proposer’s qualifications and experience (30 points), a competitive yet structured fee proposal (25 points), and finally equity, diversity, and inclusion efforts (10 points). The contract is structured on an on-call basis, with specific work initiated through CareOregon Scope of Work forms, incorporating rigorous requirements such as HIPAA compliance, background checks, key personnel designation, and restrictions on offshore services. Contractors must meet stringent data security and insurance requirements and demonstrate alignment with CareOregon’s mission and regulatory mandates. Proposals must be submitted electronically by January 6, 2026, with the award based on a best-value, trade-off analysis rather than simply the lowest price. Overall, this solicitation underscores a comprehensive risk-based approach to managing kidney disease populations while ensuring high accountability, clinical integrity, and compliance with federal and state healthcare program requirements.